United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - sodium chloride 526 mg in 100 ml - normosol-r ph 7.4 is indicated for replacement of acute extracellular fluid volume losses in surgery, trauma, burns or shock. normosol-r ph 7.4 also can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss. normosol-r ph 7.4 is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume. normosol-r ph 7.4 is particularly valuable as a solution for use in starting blood, i.e., as a priming solution for the infusion set. no hemolysis of blood is seen at the interface or with mixed solution and blood. it may also be used as a diluent to aid in the transfusion of packed red blood cells (prbc). normosol-r ph 7.4 and physiologic saline solution (0.9% sodium chloride injection, usp) are compatible with both young and old prbc. none known.

United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - sodium chloride 526 mg in 100 ml - physiosol™ is indicated for all general irrigation, washing and rinsing purposes which permit use of a sterile, nonpyrogenic electrolyte solution. not for injection by usual parenteral routes. an electrolyte solution should not be used for irrigation during electrosurgical procedures.

United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc) - sodium chloride 321 mg in 20 ml - tpn electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients. tpn electrolytes (multiple electrolyte additive) is contraindicated in pathological conditions where additives of potassium, sodium, calcium, magnesium or chloride could be clinically deleterious, e.g., anuria, hyperkalemia, heart block or myocardial damage and severe edema due to cardiovascular, renal or hepatic failure. none known.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

United States - English - NLM (National Library of Medicine)

sypharma pty ltd - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37, gluconic acid - unii:r4r8j0q44b), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - sodium chloride 526 mg in 100 ml - sykes iv lyte-r injection (multiple electrolytes injection, type 1, usp) is indicated as a source of water and electrolytes for all species. it is also used as an alkalinizing agent. none known

United States - English - NLM (National Library of Medicine)

icu medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - normosol-r ph 7.4 is indicated for replacement of acute extracellular fluid volume losses in surgery, trauma, burns or shock. normosol-r ph 7.4 also can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss. normosol-r ph 7.4 is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume. normosol-r ph 7.4 is particularly valuable as a solution for use in starting blood, i.e., as a priming solution for the infusion set. no hemolysis of blood is seen at the interface or with mixed solution and blood. it may also be used as a diluent to aid in the transfusion of packed red blood cells (prbc). normosol-r ph 7.4 and physiologic saline solution (0.9% sodium chloride injection, usp) are compatible with both young and old prbc. none known.

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp - 5% dextrose in acetated ringer's solution - solution for iv infusion - each 100 ml contains 5 g dextrose monohydrate, 600 mg sodium chloride, 228 mg sodium acetate, anhydrous, 30 mg potassium chlorid

Malta - English - Medicines Authority

b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - calcium chloride, dihydrate, phenylalanine, potassium acetate, histidine, arginine, aspartic acid, threonine, triglycerides medium, chain, valine, zinc acetate, glucose, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium acetate, serine, proline, sodium acetate, trihydrate, sodium chloride, sodium dihydrogen, phosphate dihydrate, sodium hydroxide, soya oil - emulsion for infusion - calcium chloride dihydrate 0.353 g/l phenylalanine 2.81 g/l potassium acetate 2.354 g/l histidine 1 g/l arginine 2.16 g/l aspartic acid 1.2 g/l alanine 3.88 g/l threonine 1.46 g/l triglycerides medium chain 20 g/l valine 2.08 g/l zinc acetate dihydrate 5.3 g/l glucose 64 g/l glutamic acid 2.8 g/l glycine 1.32 g/l methionine 1.57 g/l isoleucine 1.87 g/l l-tryptophan 0.46 g/l lysine 1.81 g/l magnesium acetate 0.515 g/l serine 2.4 g/l leucine 2.5 g/l proline 2.72 g/l sodium acetate trihydrate 0.435 g/l sodium chloride 0.865 g/l sodium dihydrogen phosphate dihydrate 0.936 g/l sodium hydroxide 0.64 g/l soya oil 20 g/l - blood substitutes and perfusion solutions

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.